180 related articles for article (PubMed ID: 13199)
1. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex.
Biggio G; Brodie BB; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3592-6. PubMed ID: 198792
[TBL] [Abstract][Full Text] [Related]
3. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
Biggio G; Costa E; Guidotti A
Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
[No Abstract] [Full Text] [Related]
4. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
Mailman RB; Frye GD; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
[TBL] [Abstract][Full Text] [Related]
5. Climbing fiver activation and 3', 5'-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellum.
Biggio G; Guidotti A
Brain Res; 1976 May; 107(2):365-73. PubMed ID: 178409
[TBL] [Abstract][Full Text] [Related]
6. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
Biggio G; Corda MG; Casu M; Gessa GL
Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
[No Abstract] [Full Text] [Related]
7. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
Biggio G; Corda MG; Casu M; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
[TBL] [Abstract][Full Text] [Related]
8. 3-Acetylpyridine: a tool to inhibit the tremor and the increase of cGMP content in cerebellar cortex elicited by harmaline.
Guidotti A; Biggio G; Costa E
Brain Res; 1975 Oct; 96(1):201-5. PubMed ID: 169960
[No Abstract] [Full Text] [Related]
9. Inhibition of climbing and mossy fiber input to mouse cerebellar Purkinje cells by cholecystokinin.
Wood PL; Steel DJ; Kim HS; Petrack B; Altar CA
J Pharmacol Exp Ther; 1988 Jan; 244(1):58-62. PubMed ID: 2826774
[TBL] [Abstract][Full Text] [Related]
10. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
Burkard WP; Pieri L; Haefely W
Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
[TBL] [Abstract][Full Text] [Related]
11. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists.
Biggio G; Guidotti A; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors.
Marcoli M; Cervetto C; Paluzzi P; Guarnieri S; Raiteri M; Maura G
Neurochem Int; 2006 Jul; 49(1):12-9. PubMed ID: 16469416
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar output regulation by the climbing and mossy fibers with and without the inferior olive.
Bardin JM; Batini C; Billard JM; Buisseret-Delmas C; Conrath-Verrier M; Corvaja N
J Comp Neurol; 1983 Feb; 213(4):464-77. PubMed ID: 6300201
[TBL] [Abstract][Full Text] [Related]
14. Regulation of 3', 5'-cyclic guanosine monophosphate content in deep cerebellar nuclei.
Biggio G; Costa E; Guidotti A
Neuroscience; 1977; 2(1):49-52. PubMed ID: 199855
[No Abstract] [Full Text] [Related]
15. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
DeRubertis FR; Craven P
Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action diazepam.
Mao CC; Guidotti A; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(4):369-78. PubMed ID: 240134
[TBL] [Abstract][Full Text] [Related]
17. Correlations between cerebellar cyclic GMP and motor effects induced by deltamethrin: independence of olivo-cerebellar tract.
Brodie ME
Neurotoxicology; 1983; 4(4):1-11. PubMed ID: 6322058
[TBL] [Abstract][Full Text] [Related]
18. Harmaline-induced climbing fiber activation causes amino acid and peptide release in the rodent cerebellar cortex and a unique temporal pattern of Fos expression in the olivo-cerebellar pathway.
Beitz AJ; Saxon D
J Neurocytol; 2004 Jan; 33(1):49-74. PubMed ID: 15173632
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study.
Luo D; Leung E; Vincent SR
J Neurosci; 1994 Jan; 14(1):263-71. PubMed ID: 7506765
[TBL] [Abstract][Full Text] [Related]
20. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
Scatton B; Claustre Y; Dennis T; Nishikawa T
J Pharmacol Exp Ther; 1986 May; 237(2):659-65. PubMed ID: 2871179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
